Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice

Bone

Volumn 39, Issue 1, 2006, Pages 53-60

  Blin Wakkach, Claudine ^a   Breuil, Véronique ^a,b   Quincey, Danielle ^a   Bagnis, Claude ^c   Carle, Georges F ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Cell line; Mouse model; Osteoclast; Osteopetrosis

Indexed keywords

INTERLEUKIN 3; LENTIVIRUS VECTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN P53;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACKCROSSING; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HETEROZYGOSITY; HOMOZYGOTE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; REGULATOR GENE; SPONTANEOUS MUTATION; T CELL IMMUNE REGULATOR GENE; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CARRIER PROTEINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CROSSES, GENETIC; FEMUR; GENETIC VECTORS; HETEROZYGOTE; HOMOZYGOTE; LENTIVIRUS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; OSTEOCLASTS; OSTEOPETROSIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STEM CELLS; TIME FACTORS; TRANSFECTION;

EID: 33744929844     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.12.078     Document Type: Article

References (29)

1. Wilson C.J., and Vellodi A. Autosomal recessive osteopetrosis: diagnosis, management, and outcome. Arch. Dis. Child. 83 (2000) 449-452
2. Seifert M.F., and Marks Jr. S.C. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse. Am. J. Anat. 172 (1985) 141-153
3. Blin-Wakkach C., Wakkach A., Sexton P.M., Rochet N., and Carle G.F. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis. Leukemia 18 (2004) 1505-1511
4. Scimeca J.C., Franchi A., Trojani C., Parrinello H., Grosgeorge J., Robert C., et al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26 (2000) 207-213
5. Frattini A., Orchard P.J., Sobacchi C., Giliani S., Abinun M., Mattsson J.P., et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25 (2000) 343-346
6. Kornak U., Schulz A., Friedrich W., Uhlhaas S., Kremens B., Voit T., et al. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9 (2000) 2059-2063
7. Sobacchi C., Frattini A., Orchard P., Porras O., Tezcan I., Andolina M., et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum. Mol. Genet. 10 (2001) 1767-1773
8. Scimeca J.C., Quincey D., Parrinello H., Romatet D., Grosgeorge J., Gaudray P., et al. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum. Mutat. 21 (2003) 151-157
9. Nakamura I., Takahashi N., Udagawa N., Moriyama Y., Kurokawa T., Jimi E., et al. Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice. FEBS Lett. 401 (1997) 207-212
10. Taranta A., Migliaccio S., Recchia I., Caniglia M., Luciani M., De Rossi G., et al. Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis. Am. J. Pathol. 162 (2003) 57-68
11. Chambers T.J., Owens J.M., Hattersley G., Jat P.S., and Noble M.D. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5578-5582
12. Chen W., and Li Y.P. Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen. J. Bone Miner. Res. 13 (1998) 1112-1123
13. Miyamoto A., Kunisada T., Hemmi H., Yamane T., Yasuda H., Miyake K., et al. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem. Biophys. Res. Commun. 242 (1998) 703-709
14. Harvey M., McArthur M.J., Montgomery Jr. C.A., Butel J.S., Bradley A., and Donehower L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5 (1993) 225-229
15. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4 (1994) 1-7
16. Quinn J.M., Morfis M., Lam M.H., Elliott J., Kartsogiannis V., Williams E.D., et al. Calcitonin receptor antibodies in the identification of osteoclasts. Bone 25 (1999) 1-8
17. Rouas R., Uch R., Cleuter Y., Jordier F., Bagnis C., Mannoni P., et al. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther. 9 (2002) 715-724
18. Blin-Wakkach C., Wakkach A., Rochet N., and Carle G.F. Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mouse. J. Bone Miner. Res. 7 (2004) 1137-1143
19. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000) 275-286
20. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13 (1999) 2412-2424
21. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99 (2002) 111-120
22. Tondravi M.M., McKercher S.R., Anderson K., Erdmann J.M., Quiroz M., Maki R., et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386 (1997) 81-84
23. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 (1994) 443-448
24. Gattei V., Bernabei P.A., Pinto A., Bezzini R., Ringressi A., Formigli L., et al. Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1). J. Cell Biol. 116 (1992) 437-447
25. Gilad G.M., and Gilad V.H. Strain, stress, neurodegeneration and longevity. Mech. Ageing Dev. 78 (1995) 75-83
26. Beamer W.G., Donahue L.R., Rosen C.J., and Baylink D.J. Genetic variability in adult bone density among inbred strains of mice. Bone 18 (1996) 397-403
27. Charles P.C., Weber K.S., Cipriani B., and Brosnan C.F. Cytokine, chemokine and chemokine receptor mRNA expression in different strains of normal mice: implications for establishment of a Th1/Th2 bias. J. Neuroimmunol. 100 (1999) 64-73
28. Dickie M. Osteosclerotic (oc). Mouse News Lett. 36 (1967) 39
29. Chambers T.J. Regulation of the differentiation and function of osteoclasts. J. Pathol. 192 (2000) 4-13